TCM
IDXX icon

Tuttle Capital Management’s Idexx Laboratories IDXX Stock Holding History

Tuttle Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,794
Closed -$592K – 158
2020
Q2 		$592K Buy
1,794
+645
+56% +$187K 0.42% 63
2020
Q1 		$278K Sell
1,149
-1,921
-63% -$501K 0.15% 62
2019
Q4 		$802K Sell
3,070
-3,662
-54% -$965K 0.3% 66
2019
Q3 		$1.95M Buy
+6,732
New +$1.87M 0.52% 60
2019
Q2 		– Sell
-9,375
Closed -$2.1M – 131
2019
Q1 		$2.1M Buy
+9,375
New +$1.94M 0.42% 77

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Tuttle Capital Management's IDXX Position: Q3 2020 in Review

Tuttle Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2020, closing a stake of 1,794 shares — an estimated $592K sold.

Tuttle Capital Management first reported a position in IDXX in Q1 2019 and held it in 5 quarters. The position peaked at $2.1M in Q1 2019. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

  • Tuttle Capital Management reported no remaining Idexx Laboratories position as of Q3 2020 after selling out during the quarter.
  • Tuttle Capital Management sold 1,794 Idexx Laboratories shares in Q3 2020, an estimated $592K.
  • Tuttle Capital Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 5 quarters.
  • Tuttle Capital Management's Idexx Laboratories position peaked at $2.1M in Q1 2019.
  • 846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on Tuttle Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.